Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy.

Idiopathic membranous nephropathy (IMN) is one of the most frequent causes of the nephrotic syndrome in adults and one of the most common cause of chronic renal failure among primary glomerular diseases. The aim of this study was to develop artificial neural networks (ANN) to investigate factors of poor outcome for IMN and to evaluate the efficacy of different therapeutic protocols. Data were collected retrospectively for 124 patients with IMN (82 males, mean based on the received therapy patients were divided into three groups: corticosteroids only (group 1), cyclophsophamide with corticosteroids (group 2), and so called Ponticelli protocol (group 3). After achieving satisfactory truthfulness of the transcription function of ANN through clustering, we have applied the efficacy analysis to all patients and then compared them to each group separately, and evaluated the influence of initial characteristics on disease outcome as well as the therapy efficacy. The greatest therapy inefficiency was recorded for isolated corticosteroid therapy (29.41%) and the smallest inefficiency for Ponticelli protocol, for which the greatest accuracy of prognosis was recorded (82.09%). The greatest negative prognostic influence had kidney insufficiency (22%), quantitative proteinuria (15%) and index of interstitial infiltration (14%). Based on our results, we can recommend that patients diagnosed with IMN with renal insufficiency, nephrotic syndrome or a high degree of interstitial infiltration at the time of diagnosis should be treated concomitantly with cytotoxic drugs and corticosteroids, particularly with the Ponticelli protocol.

[1]  D. C. Cattran,et al.  Idiopathic membranous glomerulonephritis. , 2001, Kidney international.

[2]  A. Lupo,et al.  A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. , 1998, Journal of the American Society of Nephrology : JASN.

[3]  M. Leontsini,et al.  Relationship between interstitial infiltrates and steroid responsiveness of proteinuria in membranous nephropathy. , 1994, Nephrology, Dialysis and Transplantation.

[4]  G. Remuzzi,et al.  Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  A. Magil,et al.  Focal glomerulosclerosis in idiopathic membranous glomerulonephritis. , 1992, Kidney international.

[6]  M. Raftery,et al.  Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy. , 1995, Kidney international.

[7]  B. Marx,et al.  Prediction in idiopathic membranous nephropathy. , 1999, Kidney international.

[8]  J. Wetzels,et al.  Prognostic factors in idiopathic membranous nephropathy. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  R. Falk,et al.  A review of therapeutic studies of idiopathic membranous glomerulopathy. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  C. Cardella,et al.  A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. , 1989, The New England journal of medicine.

[11]  E. Jones,et al.  Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  Tom Greene,et al.  Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  G. D'Amico,et al.  Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  N. Yorioka,et al.  Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. , 2004, Kidney international.

[15]  G. Schumm,et al.  Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes. , 1990, Clinical nephrology.

[16]  T. Greene,et al.  Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.

[17]  R. Glassock Diagnosis and natural course of membranous nephropathy. , 2003, Seminars in nephrology.

[18]  T. Saruta,et al.  Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy. , 1992, Clinical nephrology.

[19]  F. Locatelli,et al.  A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. , 1995, Kidney international.

[20]  C. Ponticelli,et al.  Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group. , 1992, The New England journal of medicine.

[21]  Sunil V. Rao,et al.  Management of glomerular proteinuria: a commentary. , 2003, Journal of the American Society of Nephrology : JASN.

[22]  J. Velosa,et al.  Idiopathic membranous nephropathy: the natural history of untreated patients. , 1988, Kidney international.

[23]  Y. Pei,et al.  Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. , 1992, Kidney international.

[24]  M. Burnier,et al.  Usefulness of artificial neural networks to predict follow-up dietary protein intake in hemodialysis patients. , 2004, Kidney international.

[25]  M. Endoh,et al.  Analysis of prognostic predictors in idiopathic membranous nephropathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  K. Simpson,et al.  An artificial neural network can select patients at high risk of developing progressive IgA nephropathy more accurately than experienced nephrologists. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  D. Shoskes,et al.  Prediction of early graft function in renal transplantation using a computer neural network. , 1998, Transplantation Proceedings.

[28]  R. Glassock The treatment of idiopathic membranous nephropathy: a dilemma or a conundrum? , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  N. Muirhead Management of idiopathic membranous nephropathy: evidence-based recommendations. , 1999, Kidney international. Supplement.

[30]  Drasko Furundzic,et al.  Neural networks approach to early breast cancer detection , 1998, J. Syst. Archit..

[31]  S. Takebayashi,et al.  Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and in adult Japanese. , 1987, Clinical nephrology.

[32]  J. Wetzels,et al.  Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency. , 1998, QJM : monthly journal of the Association of Physicians.